Kingsview Wealth Management’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $523K | Buy |
5,478
+1,014
| +23% | +$97.3K | 0.01% | 964 |
|
|
2026
Q1 | $463K | Sell |
4,464
-244
| -5% | -$27.7K | 0.01% | 928 |
|
|
2025
Q4 | $475K | Sell |
4,708
-703
| -13% | -$76.3K | 0.01% | 861 |
|
|
2025
Q3 | $667K | Sell |
5,411
-132
| -2% | -$16.4K | 0.01% | 716 |
|
|
2025
Q2 | $666K | Sell |
5,543
-61
| -1% | -$8.14K | 0.01% | 677 |
|
|
2025
Q1 | $825K | Sell |
5,604
-39
| -0.7% | -$5.96K | 0.02% | 595 |
|
|
2024
Q4 | $916K | Buy |
5,643
+177
| +3% | +$29K | 0.02% | 572 |
|
|
2024
Q3 | $890K | Sell |
5,466
-1,443
| -21% | -$214K | 0.02% | 563 |
|
|
2024
Q2 | $943K | Buy |
6,909
+395
| +6% | +$54.9K | 0.02% | 526 |
|
|
2024
Q1 | $997K | Buy |
6,514
+43
| +0.7% | +$6.42K | 0.03% | 497 |
|
|
2023
Q4 | $923K | Sell |
6,471
-11,389
| -64% | -$1.52M | 0.03% | 488 |
|
|
2023
Q3 | $2.34M | Buy |
17,860
+11,707
| +190% | +$1.78M | 0.08% | 245 |
|
|
2023
Q2 | $979K | Sell |
6,153
-210
| -3% | -$33.9K | 0.04% | 417 |
|
|
2023
Q1 | $1.01M | Buy |
6,363
+130
| +2% | +$19.5K | 0.04% | 395 |
|
|
2022
Q4 | $875K | Sell |
6,233
-579
| -8% | -$82.2K | 0.04% | 371 |
|
|
2022
Q3 | $875K | Buy |
6,812
+384
| +6% | +$55.4K | 0.04% | 357 |
|
|
2022
Q2 | $906K | Buy |
6,428
+635
| +11% | +$90.7K | 0.04% | 392 |
|
|
2022
Q1 | $805K | Buy |
5,793
+21
| +0.4% | +$3.22K | 0.04% | 455 |
|
|
2021
Q4 | $1.01M | Sell |
5,772
-155
| -3% | -$25.8K | 0.04% | 404 |
|
|
2021
Q3 | $982K | Buy |
5,927
+2,267
| +62% | +$390K | 0.05% | 383 |
|
|
2021
Q2 | $655K | Buy |
3,660
+628
| +21% | +$115K | 0.03% | 488 |
|
|
2021
Q1 | $585K | Sell |
3,032
-109
| -3% | -$21K | 0.03% | 476 |
|
|
2020
Q4 | $634K | Sell |
3,141
-803
| -20% | -$166K | 0.05% | 389 |
|
|
2020
Q3 | $829K | Sell |
3,944
-2,099
| -35% | -$467K | 0.07% | 261 |
|
|
2020
Q2 | $1.33M | Buy |
6,043
+4,055
| +204% | +$810K | 0.13% | 171 |
|
|
2020
Q1 | $344K | Buy |
1,988
+395
| +25% | +$65.3K | 0.05% | 318 |
|
|
2019
Q4 | $245K | Sell |
1,593
-369
| -19% | -$55.1K | 0.03% | 405 |
|
|
2019
Q3 | $298K | Buy |
1,962
+555
| +39% | +$87.7K | 0.05% | 336 |
|
|
2019
Q2 | $215K | Buy |
+1,407
| New | +$215K | 0.04% | 382 |
|
|
2018
Q3 | – | Sell |
-2,227
| Closed | -$301K | – | 418 |
|
|
2018
Q2 | $301K | Buy |
2,227
+139
| +7% | +$17.2K | 0.07% | 263 |
|
|
2018
Q1 | $278K | Buy |
2,088
+63
| +3% | +$8.46K | 0.07% | 264 |
|
|
2017
Q4 | $301K | Buy |
+2,025
| New | +$276K | 0.11% | 242 |
|
Other funds holding CLX
Kingsview Wealth Management's CLX Position: Q2 2026 in Review
Kingsview Wealth Management increased its Clorox (CLX) stake by 23% in Q2 2026, buying an estimated $97.3K and bringing the position to 5,478 shares worth $523K. The position accounts for 0.01% of the portfolio, ranked #964.
Kingsview Wealth Management first reported a position in CLX in Q4 2017 and has held it in 32 quarters since. The position peaked at $2.34M in Q3 2023. 1,044 funds tracked by Wall St. Rank hold CLX as of Q2 2026.
- Kingsview Wealth Management held 5,478 shares of Clorox worth $523K as of Q2 2026.
- Kingsview Wealth Management bought 1,014 Clorox shares in Q2 2026, an estimated $97.3K.
- Clorox made up 0.01% of Kingsview Wealth Management's portfolio in Q2 2026, its #964 holding.
- Kingsview Wealth Management first reported a position in Clorox in Q4 2017 and has held it in 32 quarters since.
- Kingsview Wealth Management's Clorox position peaked at $2.34M in Q3 2023.
- 1,044 funds tracked by Wall St. Rank held Clorox as of Q2 2026.
Based on Kingsview Wealth Management's 13F filing for Q2 2026, filed 19 Aug 2026.